Form 4: Merck Director Kathy Warden Acquires Phantom Stock
Statement of Changes in Beneficial Ownership
Merck & Co., Inc. director Kathy J. Warden acquired 1,853.0997 phantom stock units, settled in cash upon termination of service.
Summary
- Director Kathy J. Warden acquired 1,853.0997 phantom stock units on May 29, 2026.
- These phantom stock units are to be settled 100% in cash upon the reporting person's termination of service.
- The settlement will occur in accordance with a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
- The underlying securities are common stock of Merck & Co., Inc. (MRK).
- The acquisition price for the phantom stock was $118.72 per share.
- Following this transaction, Warden beneficially owns 17,890.2917 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation transaction for a director rather than a significant event impacting the company's financial performance or strategic direction.
Positives
- Director Kathy J. Warden has acquired additional phantom stock units, indicating continued commitment and alignment with the company's performance.
- The phantom stock units are to be settled in cash, providing a direct financial benefit to the director upon service termination.
Future Outlook
Phantom stock units are to be settled in cash upon the reporting person's termination of service, according to an elected distribution schedule.
Industry Context
StockSavvy.ai notes that this Form 4 filing details a common practice for director compensation in the pharmaceutical industry, where phantom stock units are used to align executive interests with shareholder value and provide deferred compensation.
Related Party Transactions
- Acquisition of phantom stock units by Director Kathy J. Warden.
Stakeholder Impact
- Shareholders: The transaction reflects standard director compensation practices and does not immediately impact share count or dilution. It signifies continued director engagement.
- Employees: No direct impact on employees.
- Management: The transaction is part of the executive compensation structure.
Next Steps
- Settlement of phantom stock units in cash upon reporting person's termination of service.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Transaction Date for acquisition of phantom stock units. |
| 06/02/2026 | Date of filing of the statement. |
Keywords
Form 4, SEC Filing, Insider Trading, Stock Options, Phantom Stock, Merck & Co., MRK, Director Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.